EMEA (Europe, Middle East and Africa) Liver Fibrosis Drug Market Report 2017

December 2017 | 117 pages | ID: E1BC71FFC77EN
QYResearch

Abstracts

In this report, the EMEA Liver Fibrosis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Liver Fibrosis Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Liver Fibrosis Drug market competition by top manufacturers/players, with Liver Fibrosis Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bird Rock Bio, Inc.
• Bristol-Myers Squibb Company
• Celgene Corporation
• Dicerna Pharmaceuticals, Inc.
• Digna Biotech, S.L.
• Genfit SA
• Gilead Sciences, Inc.
• GNI Group Ltd.
• HEC Pharm Co., Ltd.
• Dr. Falk Pharma GmbH
• LG Life Science LTD.
• Nitto Denko Corporation
• Pfizer Inc.
• Pharmaxis Limited
• Promedior, Inc.
• Dynavax Technologies Corporation
• Evotec AG
• FibroGen, Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Interferon
• Maloti Lipid
• Nucleoside
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Research Center
• Hospital
• Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Liver Fibrosis Drug Market Report 2017

1 LIVER FIBROSIS DRUG OVERVIEW

1.1 Product Overview and Scope of Liver Fibrosis Drug
1.2 Classification of Liver Fibrosis Drug
  1.2.1 EMEA Liver Fibrosis Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Liver Fibrosis Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Interferon
  1.2.4 Maloti Lipid
  1.2.5 Nucleoside
  1.2.6 Other
1.3 EMEA Liver Fibrosis Drug Market by Application/End Users
  1.3.1 EMEA Liver Fibrosis Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Research Center
  1.3.3 Hospital
  1.3.4 Clinic
1.4 EMEA Liver Fibrosis Drug Market by Region
  1.4.1 EMEA Liver Fibrosis Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Liver Fibrosis Drug (2012-2022)
  1.5.1 EMEA Liver Fibrosis Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Liver Fibrosis Drug Revenue and Growth Rate (2012-2022)

2 EMEA LIVER FIBROSIS DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Liver Fibrosis Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Liver Fibrosis Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Liver Fibrosis Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Liver Fibrosis Drug Sale Price by Players (2012-2017)
2.2 EMEA Liver Fibrosis Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Liver Fibrosis Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Liver Fibrosis Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Liver Fibrosis Drug Sale Price by Type (2012-2017)
2.3 EMEA Liver Fibrosis Drug (Volume) by Application
2.4 EMEA Liver Fibrosis Drug (Volume and Value) by Region
  2.4.1 EMEA Liver Fibrosis Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Liver Fibrosis Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Liver Fibrosis Drug Sales Price by Region (2012-2017)

3 EUROPE LIVER FIBROSIS DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Liver Fibrosis Drug Sales and Value (2012-2017)
  3.1.1 Europe Liver Fibrosis Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Liver Fibrosis Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Liver Fibrosis Drug Sales and Market Share by Type
3.3 Europe Liver Fibrosis Drug Sales and Market Share by Application
3.4 Europe Liver Fibrosis Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Liver Fibrosis Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Liver Fibrosis Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Liver Fibrosis Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST LIVER FIBROSIS DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Liver Fibrosis Drug Sales and Value (2012-2017)
  4.1.1 Middle East Liver Fibrosis Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Liver Fibrosis Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Liver Fibrosis Drug Sales and Market Share by Type
4.3 Middle East Liver Fibrosis Drug Sales and Market Share by Application
4.4 Middle East Liver Fibrosis Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Liver Fibrosis Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Liver Fibrosis Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Liver Fibrosis Drug Sales and Growth Rate (2012-2017)

5 AFRICA LIVER FIBROSIS DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Liver Fibrosis Drug Sales and Value (2012-2017)
  5.1.1 Africa Liver Fibrosis Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Liver Fibrosis Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Liver Fibrosis Drug Sales and Market Share by Type
5.3 Africa Liver Fibrosis Drug Sales and Market Share by Application
5.4 Africa Liver Fibrosis Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Liver Fibrosis Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Liver Fibrosis Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Liver Fibrosis Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Liver Fibrosis Drug Sales and Growth Rate (2012-2017)

6 EMEA LIVER FIBROSIS DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bird Rock Bio, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bird Rock Bio, Inc. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Celgene Corporation
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Celgene Corporation Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Dicerna Pharmaceuticals, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Digna Biotech, S.L.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Digna Biotech, S.L. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Genfit SA
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Genfit SA Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Gilead Sciences, Inc.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Gilead Sciences, Inc. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GNI Group Ltd.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GNI Group Ltd. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 HEC Pharm Co., Ltd.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 HEC Pharm Co., Ltd. Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Dr. Falk Pharma GmbH
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Liver Fibrosis Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Dr. Falk Pharma GmbH Liver Fibrosis Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 LG Life Science LTD.
6.12 Nitto Denko Corporation
6.13 Pfizer Inc.
6.14 Pharmaxis Limited
6.15 Promedior, Inc.
6.16 Dynavax Technologies Corporation
6.17 Evotec AG
6.18 FibroGen, Inc.

7 LIVER FIBROSIS DRUG MANUFACTURING COST ANALYSIS

7.1 Liver Fibrosis Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Liver Fibrosis Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Liver Fibrosis Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Liver Fibrosis Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA LIVER FIBROSIS DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Liver Fibrosis Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Liver Fibrosis Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Liver Fibrosis Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Liver Fibrosis Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Liver Fibrosis Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Liver Fibrosis Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Liver Fibrosis Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Liver Fibrosis Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Liver Fibrosis Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Liver Fibrosis Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Liver Fibrosis Drug
Figure EMEA Liver Fibrosis Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Liver Fibrosis Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Interferon Product Picture
Figure Maloti Lipid Product Picture
Figure Nucleoside Product Picture
Figure Other Product Picture
Figure EMEA Liver Fibrosis Drug Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Liver Fibrosis Drug by Application in 2016
Figure Research Center Examples
Table Key Downstream Customer in Research Center
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure EMEA Liver Fibrosis Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Liver Fibrosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Liver Fibrosis Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Liver Fibrosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Liver Fibrosis Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Liver Fibrosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Liver Fibrosis Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Liver Fibrosis Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Liver Fibrosis Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Liver Fibrosis Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Liver Fibrosis Drug Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Liver Fibrosis Drug Sales Share by Players (2012-2017)
Figure 2016 Liver Fibrosis Drug Sales Share by Players
Figure 2017 Liver Fibrosis Drug Sales Share by Players
Figure EMEA Liver Fibrosis Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Liver Fibrosis Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Liver Fibrosis Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Liver Fibrosis Drug Revenue Share by Players
Table 2017 EMEA Liver Fibrosis Drug Revenue Share by Players
Table EMEA Liver Fibrosis Drug Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Liver Fibrosis Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Liver Fibrosis Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Liver Fibrosis Drug by Type (2012-2017)
Figure EMEA Liver Fibrosis Drug Sales Market Share by Type (2012-2017)
Table EMEA Liver Fibrosis Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Liver Fibrosis Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Liver Fibrosis Drug by Type in 2016
Table EMEA Liver Fibrosis Drug Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Liver Fibrosis Drug Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Liver Fibrosis Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Liver Fibrosis Drug by Application (2012-2017)
Figure EMEA Liver Fibrosis Drug Sales Market Share by Application in 2016
Table EMEA Liver Fibrosis Drug Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Liver Fibrosis Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Liver Fibrosis Drug by Region (2012-2017)
Figure EMEA Liver Fibrosis Drug Sales Market Share in 2016
Table EMEA Liver Fibrosis Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Liver Fibrosis Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Liver Fibrosis Drug by Region (2012-2017)
Figure EMEA Liver Fibrosis Drug Revenue Market Share Regions in 2016
Table EMEA Liver Fibrosis Drug Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Liver Fibrosis Drug Revenue and Growth Rate (2012-2017)
Table Europe Liver Fibrosis Drug Sales (K Pcs) by Type (2012-2017)
Table Europe Liver Fibrosis Drug Market Share by Type (2012-2017)
Figure Europe Liver Fibrosis Drug Market Share by Type in 2016
Table Europe Liver Fibrosis Drug Sales (K Pcs) by Application (2012-2017)
Table Europe Liver Fibrosis Drug Market Share by Application (2012-2017)
Figure Europe Liver Fibrosis Drug Market Share by Application in 2016
Table Europe Liver Fibrosis Drug Sales (K Pcs) by Countries (2012-2017)
Table Europe Liver Fibrosis Drug Sales Market Share by Countries (2012-2017)
Figure Europe Liver Fibrosis Drug Sales Market Share by Countries (2012-2017)
Figure Europe Liver Fibrosis Drug Sales Market Share by Countries in 2016
Table Europe Liver Fibrosis Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Liver Fibrosis Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Liver Fibrosis Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Liver Fibrosis Drug Revenue Market Share by Countries in 2016
Figure Germany Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Liver Fibrosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Liver Fibrosis Drug Sales (K Pcs) by Type (2012-2017)
Table Middle East Liver Fibrosis Drug Market Share by Type (2012-2017)
Figure Middle East Liver Fibrosis Drug Market Share by Type (2012-2017)
Table Middle East Liver Fibrosis Drug Sales (K Pcs) by Applications (2012-2017)
Table Middle East Liver Fibrosis Drug Market Share by Applications (2012-2017)
Figure Middle East Liver Fibrosis Drug Sales Market Share by Application in 2016
Table Middle East Liver Fibrosis Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Liver Fibrosis Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Liver Fibrosis Drug Sales Volume Market Share by Countries in 2016
Table Middle East Liver Fibrosis Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Liver Fibrosis Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Liver Fibrosis Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Liver Fibrosis Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Liver Fibrosis Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Liver Fibrosis Drug Sales (K Pcs) by Type (2012-2017)
Table Africa Liver Fibrosis Drug Sales Market Share by Type (2012-2017)
Figure Africa Liver Fibrosis Drug Sales Market Share by Type (2012-2017)
Figure Africa Liver Fibrosis Drug Sales Market Share by Type in 2016
Table Africa Liver Fibrosis Drug Sales (K Pcs) by Application (2012-2017)
Table Africa Liver Fibrosis Drug Sales Market Share by Application (2012-2017)
Figure Africa Liver Fibrosis Drug Sales Market Share by Application (2012-2017)
Table Africa Liver Fibrosis Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Liver Fibrosis Drug Sales Market Share by Countries (2012-2017)
Figure Africa Liver Fibrosis Drug Sales Market Share by Countries (2012-2017)
Figure Africa Liver Fibrosis Drug Sales Market Share by Countries in 2016
Table Africa Liver Fibrosis Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Liver Fibrosis Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Liver Fibrosis Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Liver Fibrosis Drug Revenue Market Share by Countries in 2016
Figure South Africa Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Table Bird Rock Bio, Inc. Liver Fibrosis Drug Basic Information List
Table Bird Rock Bio, Inc. Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bird Rock Bio, Inc. Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bird Rock Bio, Inc. Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure Bird Rock Bio, Inc. Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Company Liver Fibrosis Drug Basic Information List
Table Bristol-Myers Squibb Company Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Company Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table Celgene Corporation Liver Fibrosis Drug Basic Information List
Table Celgene Corporation Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celgene Corporation Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Celgene Corporation Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure Celgene Corporation Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Basic Information List
Table Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure Dicerna Pharmaceuticals, Inc. Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table Digna Biotech, S.L. Liver Fibrosis Drug Basic Information List
Table Digna Biotech, S.L. Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Digna Biotech, S.L. Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Digna Biotech, S.L. Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure Digna Biotech, S.L. Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table Genfit SA Liver Fibrosis Drug Basic Information List
Table Genfit SA Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genfit SA Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Genfit SA Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure Genfit SA Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table Gilead Sciences, Inc. Liver Fibrosis Drug Basic Information List
Table Gilead Sciences, Inc. Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gilead Sciences, Inc. Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Gilead Sciences, Inc. Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure Gilead Sciences, Inc. Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table GNI Group Ltd. Liver Fibrosis Drug Basic Information List
Table GNI Group Ltd. Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GNI Group Ltd. Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure GNI Group Ltd. Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure GNI Group Ltd. Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table HEC Pharm Co., Ltd. Liver Fibrosis Drug Basic Information List
Table HEC Pharm Co., Ltd. Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure HEC Pharm Co., Ltd. Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure HEC Pharm Co., Ltd. Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure HEC Pharm Co., Ltd. Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table Dr. Falk Pharma GmbH Liver Fibrosis Drug Basic Information List
Table Dr. Falk Pharma GmbH Liver Fibrosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dr. Falk Pharma GmbH Liver Fibrosis Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dr. Falk Pharma GmbH Liver Fibrosis Drug Sales Market Share in EMEA (2012-2017)
Figure Dr. Falk Pharma GmbH Liver Fibrosis Drug Revenue Market Share in EMEA (2012-2017)
Table LG Life Science LTD. Liver Fibrosis Drug Basic Information List
Table Nitto Denko Corporation Liver Fibrosis Drug Basic Information List
Table Pfizer Inc. Liver Fibrosis Drug Basic Information List
Table Pharmaxis Limited Liver Fibrosis Drug Basic Information List
Table Promedior, Inc. Liver Fibrosis Drug Basic Information List
Table Dynavax Technologies Corporation Liver Fibrosis Drug Basic Information List
Table Evotec AG Liver Fibrosis Drug Basic Information List
Table FibroGen, Inc. Liver Fibrosis Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liver Fibrosis Drug
Figure Manufacturing Process Analysis of Liver Fibrosis Drug
Figure Liver Fibrosis Drug Industrial Chain Analysis
Table Raw Materials Sources of Liver Fibrosis Drug Major Manufacturers in 2016
Table Major Buyers of Liver Fibrosis Drug
Table Distributors/Traders List
Figure EMEA Liver Fibrosis Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Liver Fibrosis Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Liver Fibrosis Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Liver Fibrosis Drug Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Liver Fibrosis Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Liver Fibrosis Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Liver Fibrosis Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Liver Fibrosis Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Liver Fibrosis Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Liver Fibrosis Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Liver Fibrosis Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Liver Fibrosis Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Liver Fibrosis Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Liver Fibrosis Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Liver Fibrosis Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Liver Fibrosis Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Liver Fibrosis Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Liver Fibrosis Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Liver Fibrosis Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Liver Fibrosis Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Liver Fibrosis Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Liver Fibrosis Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Liver Fibrosis Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources